Mechanisms of aortopathy in LRP1 deficiency
LRP1 缺乏导致主动脉病的机制
基本信息
- 批准号:9888522
- 负责人:
- 金额:$ 16.32万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-12-10 至 2024-11-30
- 项目状态:已结题
- 来源:
- 关键词:AbdomenAbdominal Aortic AneurysmAcuteAddressAerobic ExerciseAldehydesAminopropionitrileAneurysmAnimal ModelAortic AneurysmAortic DiseasesAttenuatedBaltimoreBiologyBiomechanicsBlood PressureBlood VesselsCessation of lifeChestChronicCollagenCopperCountryDataDepositionDevelopmentDiseaseDissectionDoctor of PhilosophyDrug usageElastinEnzymesEventExerciseExtracellular MatrixFocal AdhesionsFoundationsGene MutationGenesGeneticGenetic DeterminismGoalsHeart RateHomeostasisHumanInflammatoryInflammatory InfiltrateKnowledgeLDL-Receptor Related Protein 1LDL-Receptor Related ProteinsLysineMaintenanceMarfan SyndromeMarylandMediatingMentorshipModelingMolecularMusMuscle ContractionPathogenesisPathway interactionsPatientsPeptide HydrolasesPhysiciansPlatelet-Derived Growth FactorPreventionProcessProtein-Lysine 6-OxidaseProteomicsPulse PressureRegulationResearch PersonnelRoleScientistSeveritiesSignal PathwaySignal TransductionSmooth Muscle MyocytesStudy SubjectThoracic Aortic AneurysmTransforming Growth Factor betaUnited StatesUniversitiesVascular DiseasesVascular Smooth Muscleage groupcrosslinkexercise interventionexperienceextracellularhuman subjectimprovedinsightmouse modelnovelpilot trialpreventprotective factorsprotein degradationshear stressskillstreadmill
项目摘要
Project Summary/Abstract
Aortic dissection and aneurysmal disease accounts for over 10,000 deaths in the United States each
year, and 1-2% of all deaths in Western countries. Consistent with prior studies that reveal that tight regulation
of the TGFβ signaling pathways is essential for vascular development and the maintenance of the vessel wall,
our preliminary data suggest overactivity of this pathway contributes to aortopathy. In addition, our preliminary
proteomic data suggests activation of the PDGF pathway in two animal models of aneurysm and dissection.
The Ucuzian lab, under the mentorship of Dr. Strickland, has utilized two murine models of aortic disease
to identify several dysregulated pathways associated with aortopathy: 1) a smooth muscle cell specific LDL
receptor-related protein 1 (LRP1) deficiency model; and 2) a lysyl oxidase (LOX) inhibition model using the drug
-aminopropionitrile (BAPN). Exciting preliminary data by the Ucuzian and Strickland labs has identified a novel
finding that mild aerobic exercise attenuates the aortopathy associated with both smLRP1 deficiency and LOX
inhibition. The objectives of this proposal are to investigate the molecular mechanisms by which aneurysms and
dissections develop, and to investigate exercise intervention to attenuate these processes. We will utilize both
a mouse models of aortopathy and a human subject study to address these questions.
Specific Aim 1. To define mechanisms underlying the development of aortic disease using two mouse
models of aortopathy. The hypothesis is that smLRP1 and LOX protects against the development of aortic
aneurysm and dissection by attenuating TGF and/or PDGF mediated signaling events.
Specific Aim 2. To define mechanisms by which mild aerobic exercise attenuates the development of
aortic disease using two mouse models of aortopathy. The hypothesis is that exercise prevents aortic
aneurysm and dissection formation by attenuating TGF and/or PDGF mediated signaling events.
Specific Aim 3. To identify dysregulated molecular pathways in patients presenting with ascending
aortic aneurysms and Type A dissections. The primary hypothesis is that TGF signaling will be activated
in human subjects presenting with thoracic aneurysms and dissections. The secondary hypothesis is that the
presence of these pathway disturbances will correlate with the severity and extent of aortic disease
presentation.
The long-term goals of Dr. Areck Ucuzian, the trainee, is to become an independent physician-scientist
in the field of Vascular Biology. His short-term goal is to cultivate the skills and experience required of a
researcher to become an independent clinician-investigator. The current proposal focuses specifically on a
fundamental mechanism of vessel wall homeostasis which prevents a broad range of vascular diseases. The
Aims of this study are planned to be completed at the Center for Vascular and Inflammatory Diseases (CVID)
and the University of Maryland, Baltimore (UMB) under the mentorship of Dr. Dudley Strickland, PhD.
项目概要/摘要
主动脉夹层和动脉瘤疾病分别导致美国 10,000 多人死亡
与西方国家所有死亡人数的 1-2% 一致,该研究表明严格的监管。
TGFβ信号通路对于血管发育和血管壁的维护至关重要,
我们的初步数据表明该通路的过度活跃会导致主动脉病。
蛋白质组数据表明,两种动脉瘤和夹层动物模型中 PDGF 通路被激活。
Ucuzian 实验室在 Strickland 博士的指导下,利用了两种主动脉疾病小鼠模型。
确定与主动脉病相关的几种失调途径:1) 平滑肌细胞特异性 LDL
受体相关蛋白 1 (LRP1) 缺陷模型;以及 2) 使用该药物的赖氨酰氧化酶 (LOX) 抑制模型
Ucuzian 和 Strickland 实验室令人兴奋的初步数据发现了一种新型的 -氨基丙腈 (BAPN)。
发现轻度有氧运动可减轻与 smLRP1 缺乏和 LOX 相关的主动脉病
该提案的目的是研究动脉瘤和抑制的分子机制。
解剖发展,并研究运动干预以减弱这些过程,我们将利用这两者。
主动脉病小鼠模型和人类受试者研究来解决这些问题。
具体目标 1. 使用两只小鼠确定主动脉疾病发生的机制
主动脉病模型的假设是smLRP1 和LOX 可以防止主动脉的发展。
通过减弱 TGF 和/或 PDGF 介导的信号事件来治疗动脉瘤和夹层。
具体目标 2. 确定轻度有氧运动减弱发展的机制
使用两种主动脉病小鼠模型研究主动脉疾病。假设运动可以预防主动脉疾病。
通过减弱 TGF 和/或 PDGF 介导的信号事件来形成动脉瘤和夹层。
具体目标 3. 确定出现上升的患者中失调的分子途径
主动脉瘤和 A 型夹层的主要假设是 TGF 信号传导将被激活。
在患有胸动脉瘤和夹层的人类受试者中,第二个假设是
这些通路紊乱的存在与主动脉疾病的严重程度和程度相关
推介会。
实习生 Areck Ucuzian 博士的长期目标是成为一名独立的医师科学家
他的短期目标是培养血管生物学领域所需的技能和经验。
研究员成为一名独立的临床医生-研究者 当前的提案特别关注于
血管壁稳态的基本机制可预防多种血管疾病。
这项研究的目标计划在血管和炎症疾病中心 (CVID) 完成
和马里兰大学巴尔的摩分校 (UMB),在 Dudley Strickland 博士的指导下。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Areck A Ucuzian其他文献
Areck A Ucuzian的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Areck A Ucuzian', 18)}}的其他基金
Mechanisms of aortopathy in LRP1 deficiency
LRP1 缺乏导致主动脉病的机制
- 批准号:
10542790 - 财政年份:2019
- 资助金额:
$ 16.32万 - 项目类别:
Mechanisms of aortopathy in LRP1 deficiency
LRP1 缺乏导致主动脉病的机制
- 批准号:
10316205 - 财政年份:2019
- 资助金额:
$ 16.32万 - 项目类别:
Mechanisms of aortopathy in LRP1 deficiency
LRP1 缺乏导致主动脉病的机制
- 批准号:
10066364 - 财政年份:2019
- 资助金额:
$ 16.32万 - 项目类别:
相似国自然基金
β-羟基丁酸通过分子伴侣介导的自噬降低巨噬细胞中NLRP3表达在腹主动脉瘤发展中的机制研究
- 批准号:82300536
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
PP2A调控内皮细胞EndMT促进腹主动脉瘤发展的机制研究
- 批准号:82370488
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
Tet2缺失介导的不确定潜能的克隆性造血(CHIP)调控NLRP3/IL-1β在腹主动脉瘤发生发展中的作用和机制
- 批准号:82371594
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
脂肪细胞分泌乳酸化HMGB1蛋白调控脂肪-巨噬细胞交叉对话诱导腹主动脉瘤形成
- 批准号:82300548
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
硫化氢调控铁稳态改善色氨酸代谢障碍在腹主动脉瘤中的作用及机制研究
- 批准号:82370476
- 批准年份:2023
- 资助金额:47 万元
- 项目类别:面上项目
相似海外基金
Role of neutrophils and eosinophils in bacterial ligand-induced vasculitis
中性粒细胞和嗜酸性粒细胞在细菌配体诱导的血管炎中的作用
- 批准号:
10668782 - 财政年份:2020
- 资助金额:
$ 16.32万 - 项目类别:
Role of neutrophils and eosinophils in bacterial ligand-induced vasculitis
中性粒细胞和嗜酸性粒细胞在细菌配体诱导的血管炎中的作用
- 批准号:
10269029 - 财政年份:2020
- 资助金额:
$ 16.32万 - 项目类别:
Role of neutrophils and eosinophils in bacterial ligand-induced vasculitis
中性粒细胞和嗜酸性粒细胞在细菌配体诱导的血管炎中的作用
- 批准号:
10462644 - 财政年份:2020
- 资助金额:
$ 16.32万 - 项目类别:
Mechanisms of aortopathy in LRP1 deficiency
LRP1 缺乏导致主动脉病的机制
- 批准号:
10316205 - 财政年份:2019
- 资助金额:
$ 16.32万 - 项目类别:
Mechanisms of aortopathy in LRP1 deficiency
LRP1 缺乏导致主动脉病的机制
- 批准号:
10066364 - 财政年份:2019
- 资助金额:
$ 16.32万 - 项目类别: